H.C. Hoover, Jr., MD
Consulting Medical Adviser
- History & Future
- Vaccinogen Timeline
- Chairman's Letter
- What is OncoVAX®?
- Driving Principles
- Management
- Facilities
- Publications
Dr. Hoover serves as a Consulting Medical Advisor for Vaccinogen and has been the one clinician involved with Dr. Michael G. Hanna, Jr., in all of the clinical trials of OncoVAX®. After working with Dr. Hanna at the NCI-Frederick as a Visiting Scientist in Immunotherapy from 1978 to 1980, he initiated the original pilot trial of active specific immunotherapy in patients with colon cancer at Johns Hopkins Hospital in 1981. He served in a medical advisory role with Organon Teknika/Biotechnology Research, PerImmune and Intracel.
Dr. Hoover received his MD from the University of Kansas School of Medicine in 1970. His surgical residency was served at the Massachusetts General Hospital and Harvard Medical School from 1970 to 1977 with a Chief Residency in 1978. He was a Clinical Associate in the Surgery Branch of the NCI, NIH in Bethesda from 1972 to 1974.
His academic and surgical career began at Johns Hopkins Medical Institutes from 1978 to 1983 where he was Assistant and then Associate Professor of Surgery and Oncology. In 1983, he became the founding Chief of Surgical Oncology and Associate Professor of Surgery at SUNY at Stony Brook, NY. In 1986, he returned to Harvard as Associate Professor of Surgery and Chief of Surgical Oncology Research at Mass General Hospital until 1995. He was Chairman of Surgery and Chief of Surgical Oncology and holder of The Anne and Carl Andersen Distinguished Chair in Surgery at the Lehigh Valley Hospital in Allentown, PA from 1995 to 2005. He simultaneously held a Professorship of Surgery at the Penn State Hershey School of Medicine. In 2005, he became the founding Director and Chief of Surgical Oncology at the Lewis Cancer and Research Pavilion at St. Joseph's/Candler Health System in Savannah, GA and in 2006 was named as Clinical Professor of Surgery at the Medical College of Georgia in Augusta and as an Eminent Scholar of the Georgia Cancer Coalition.
Dr. Hoover has had numerous honors and awards throughout his career including: Who's Who Among Students in American Colleges and Universities, Young Alumnus of the Year, Outstanding Young Men in America, Charles B. Thornton Advanced Technology Achievement Award for the development of tumor-specific human monoclonal antibodies, multiple patents with Dr. Hanna for the development of monoclonal antibodies and active-specific immunotherapy, and the Best Doctors in America. He has served on numerous editorial boards and has published nearly 100 scientific articles.